Stay updated on IDA53 Clinical Trial
Sign up to get notified when there's something new on the IDA53 Clinical Trial page.

Latest updates to the IDA53 Clinical Trial page
- Check3 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an updated version number from v2.16.0 to v2.16.1.SummaryDifference1.0%
- Check10 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.2%
- Check17 days agoNo Change Detected
- Check32 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check46 days agoChange DetectedThe webpage has undergone significant updates, including the introduction of a new clinical trial titled 'IDA53-FILOCLL09', which focuses on the safety and efficacy of combining ibrutinib and daratumumab for treating relapsed or refractory chronic lymphocytic leukemia (CLL) with TP53 dysfunction. Key collaborators and investigators have been named, and the revision number has been updated to v2.15.0.SummaryDifference46%
- Check53 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check61 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
Stay in the know with updates to IDA53 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IDA53 Clinical Trial page.